The EDD study-Evaluating new diagnostics for Alzheimer's Disease against usual care for people attending memory clinics within Australia.

The Florey Institute of Neuroscience and Mental Health0 个研究点目标入组 500 人开始时间: 2024年9月2日最近更新: 2024年9月9日

适应症

试验速览

暂无简介。

•1) Memory clinic physicians, (2) Memory clinic patients being considered for a diagnosis of Mild Cognitive Impairment or Alzheimer’s disease dementia, and (3) Patients’ care partners.
•1) Memory clinic physicians
•Specialists (or trainee specialists) who diagnose dementia as part of their usual clinical practice’, private or public.
•2) Memory clinic patients
•1. Age is greater than or equal to 40 years.
•2. Attending a memory clinic seeking assessment for cognitive concerns or dementia.
•3. Individuals assessed with dementia have an identified care partner (e.g., family member, spouse, caregiver).
•3)Memory clinic patients care partner
•An individual, aged over 18, who is nominated as a care partner by the patient.

•1) Memory clinic physicians
•Not practicing in an EDD program participating memory clinic.
•2) Memory clinic patients
•1. Memory clinic physician assesses the patient as unsuitable for dementia diagnostic workup, based on:
•a. No evidence of cognitive or behavioural impairment.
•b. Potential patient has severe dementia or other illness such that the person will receive no benefit from undergoing further investigation in the opinion of the memory clinic physician.
•2. Patient and/or ‘care partner’ is unable or unwilling to provide informed consent for the study.
•3. Amyloid pathology status obtained by PET/CSF/Blood are already known to the memory clinic physician.
•4. The patient is unable to undergo Aß-PET and FDG-PET.
•5. Individuals with advanced care directive that is in potential conflict with consent, for e.g., I don’t want to be involved in research studies”.

发起方